Treace Medical Concepts I... (TMCI)

AI Score

Unlock

6.70

0.04 (0.60%)

At close: Apr 25, 2025, 3:59 PM

6.72

0.30%

After-hours: Apr 25, 2025, 05:20 PM EDT

Treace Medical Concepts Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	68.71M	45.09M	44.45M	51.11M	62.21M	40.76M	41.95M	42.2M	49.77M	33.05M	29.97M	29.05M	33.44M	21.62M	20.65M	18.71M	24.11M	14.27M	7.74M	11.26M
Cost of Revenue	13.23M	8.95M	8.78M	10.13M	11.47M	8M	7.67M	8.04M	9.74M	6.62M	5.29M	5.51M	6.31M	4.25M	3.94M	3.33M	5.08M	2.91M	2.08M	2.39M
Gross Profit	55.48M	36.13M	35.67M	40.98M	50.74M	32.76M	34.28M	34.16M	40.03M	26.43M	24.68M	23.54M	27.13M	17.37M	16.71M	15.38M	19.02M	11.36M	5.65M	8.87M
Operating Income	-204K	-15.13M	-21.38M	-18.97M	-6.78M	-17.82M	-13.05M	-13.78M	-3.5M	-11.32M	-11.93M	-8.1M	-5.6M	-5.46M	-4.05M	-1.4M	3.63M	-63K	-1.52M	-1.2M
Interest Income	899K	1.07M	1.38M	1.53M	1.71M	1.57M	1.97M	1.48M	396K	375K	131K	11K	6K	5K	6K	1K	2K	n/a	3K	33K
Pretax Income	-501K	-15.36M	-21.21M	-18.68M	-6.28M	-17.52M	-12.27M	-13.45M	-4.41M	-12.13M	-17.23M	-9.04M	-6.62M	-6.42M	-5.08M	-2.43M	2.57M	-2.65M	-1.97M	-1.61M
Net Income	-501K	-15.36M	-21.21M	-18.68M	-6.28M	-17.52M	-12.27M	-13.13M	-3.5M	-12.95M	-17.23M	-9.98M	-6.62M	-6.42M	-5.08M	-2.43M	2.41M	-2.65M	-1.97M	-1.61M
Selling & General & Admin	50.47M	46.3M	51.9M	54.69M	53.37M	46.23M	43.8M	44.52M	39.77M	33.95M	33.63M	28.59M	29.35M	20.29M	18.34M	14.91M	13.46M	9.91M	6.19M	8.63M
Research & Development	5.21M	4.96M	5.16M	5.26M	4.15M	4.35M	3.53M	3.41M	3.75M	3.8M	2.98M	3.05M	3.38M	2.54M	2.42M	1.87M	1.92M	1.51M	982K	1.43M
Other Expenses	n/a	n/a	112K	74K	96K	23K	95K	128K	n/a	-45K	-3K	2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	55.68M	51.27M	57.06M	59.95M	57.52M	50.58M	47.33M	47.93M	43.52M	37.75M	36.61M	31.64M	32.73M	22.83M	20.76M	16.78M	15.39M	11.42M	7.17M	10.07M
Interest Expense	1.31M	1.31M	1.31M	1.32M	1.3M	1.3M	1.28M	1.28M	1.31M	1.19M	946K	951K	1.03M	963K	1.04M	1.03M	1.07M	2.59M	458K	441K
Selling & Marketing Expenses	36.86M	32.77M	37.68M	40.33M	39.92M	33.54M	33.77M	33.66M	29.37M	25.03M	26.61M	21.92M	22.32M	15.98M	14.01M	12.15M	11.43M	8.1M	4.79M	7.34M
Cost & Expenses	68.91M	60.22M	65.84M	70.08M	68.99M	58.58M	55.01M	55.97M	53.27M	44.37M	41.9M	37.14M	39.04M	27.08M	24.7M	20.11M	20.47M	14.33M	9.26M	12.46M
Income Tax Expense	n/a	n/a	n/a	1.87M	509K	-1.56M	1.38M	-322K	-917K	815K	943K	940K	1.03M	5K	6K	1K	-1.75M	n/a	3K	33K
Shares Outstanding (Basic)	62.34M	62.23M	62.08M	61.79M	61.7M	61.56M	61.38M	58.72M	55.56M	55.43M	55.31M	54.83M	53.62M	52.77M	49.19M	50.46M	50.46M	43.9M	43.9M	43.9M
Shares Outstanding (Diluted)	62.34M	62.23M	62.08M	61.79M	61.7M	61.56M	61.38M	58.72M	55.56M	55.43M	55.31M	54.83M	53.62M	52.77M	49.19M	50.46M	50.46M	43.9M	43.9M	43.9M
EPS (Basic)	-0.01	-0.25	-0.34	-0.3	-0.1	-0.28	-0.2	-0.22	-0.06	-0.23	-0.31	-0.18	-0.12	-0.12	-0.1	-0.05	0.05	-0.06	-0.04	-0.04
EPS (Diluted)	-0.01	-0.25	-0.34	-0.3	-0.1	-0.28	-0.2	-0.22	-0.06	-0.23	-0.31	-0.18	-0.12	-0.12	-0.1	-0.05	0.05	-0.06	-0.04	-0.04
EBITDA	3.05M	-11.89M	-17.78M	-15.45M	-3.21M	-14.66M	-9.26M	-10.62M	-2.18M	-10.48M	-15.04M	-7.75M	-5.32M	-5.27M	-3.94M	-1.28M	3.84M	272K	-1.16M	-895K
EBIT	813K	-14.05M	-19.89M	-17.36M	-4.98M	-16.23M	-10.99M	-12.17M	-3.1M	-10.94M	-16.29M	-8.09M	-5.59M	-5.46M	-4.04M	-1.4M	1.89M	-63K	-1.51M	-1.17M
Depreciation & Amortization	2.24M	2.16M	2.12M	1.91M	1.77M	1.56M	1.73M	1.55M	1.43M	1.3M	1.25M	334K	276K	189K	100K	117K	208K	335K	363K	304K